Oncorus
Cambridge
About Oncorus
Oncorus, Inc. is a lean early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer. Oncorus was founded MPM Managing Director Mitch Finer, a well-known biotechnology entrepreneur. Oncorus is a leader in corporate philanthropy, and has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $218.5M
- Funding stage: IPO
- Last round: Post-IPO Debt (Apr 2022)
- Ticker: nasdaq:ONCR
- Website: oncorus.com
- Phone: (857)320-6402
Industries & Categories
Biotechnology, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oncorus-175331 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.